2004
DOI: 10.1128/jb.186.5.1531-1536.2004
|View full text |Cite
|
Sign up to set email alerts
|

Evolution of a Pathway to Novel Long-Chain Carotenoids

Abstract: Using methods of laboratory evolution to force the C 30 carotenoid synthase CrtM to function as a C 40 synthase, followed by further mutagenesis at functionally important amino acid residues, we have discovered that synthase specificity is controlled at the second (rearrangement) step of the two-step reaction. We used this information to engineer CrtM variants that can synthesize previously unknown C 45 and C 50 carotenoid backbones (mono-and diisopentenylphytoenes) from the appropriate isoprenyldiphosphate pr… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
55
0

Year Published

2005
2005
2012
2012

Publication Types

Select...
5
3

Relationship

1
7

Authors

Journals

citations
Cited by 64 publications
(55 citation statements)
references
References 29 publications
0
55
0
Order By: Relevance
“…6 A and B clearly suggesting that both cationic inhibitors act as transition state-reactive intermediate analogs which occupy the S2 site, mimicking a cyclopropyl carbocation species, rather than being isosteres for the farnesyl carbocation which forms in S1. In FPPS, the cationic or nitrogen-containing bisphosphonate class of inhibitors bind to the S1 site (18,21,22), but of course most of the binding energy there can be attributed to the bisphosphonateMg 2þ 3 interaction. In the cationic inhibitors here, no such metal ion chelation is present, and binding is dominated by hydrophobic interactions with, potentially, the ammonium groups (and the cationic reaction intermediates) also being stabilized by the protein's charge field, just as in FPPS (17).…”
Section: Resultsmentioning
confidence: 99%
“…6 A and B clearly suggesting that both cationic inhibitors act as transition state-reactive intermediate analogs which occupy the S2 site, mimicking a cyclopropyl carbocation species, rather than being isosteres for the farnesyl carbocation which forms in S1. In FPPS, the cationic or nitrogen-containing bisphosphonate class of inhibitors bind to the S1 site (18,21,22), but of course most of the binding energy there can be attributed to the bisphosphonateMg 2þ 3 interaction. In the cationic inhibitors here, no such metal ion chelation is present, and binding is dominated by hydrophobic interactions with, potentially, the ammonium groups (and the cationic reaction intermediates) also being stabilized by the protein's charge field, just as in FPPS (17).…”
Section: Resultsmentioning
confidence: 99%
“…This combinatorial biosynthetic approach basically relies on the functional coordination of pathway enzymes from different sources in a heterologous host (5,19,35). Carotenogenic enzymes tend to be promiscuous in their substrate specificity (33) and show unexpected/hidden activities (20) when expressed in heterologous host microorganisms. One example is the unusual activity of diapophytoene desaturase CrtN in E. coli, which resulted in structurally novel compounds (20).…”
mentioning
confidence: 99%
“…Directed evolution experiments on CrtM have resulted in the production of a variant that can now synthesize phytoene (C40 carotenoid) from two GGPPs [141]. Additional CrtM mutants were obtained that utilize farnesylgeranyl disphopshate (C25, produced from a mutant FPP synthase from B. stearothermophilus) to produce novel C45 and C50 carotenoids [142]. As with the C35 carotenoid, the C45 and C50 carotenoids served as substrates for phytoene desaturase CrtI, to produce additional new desaturated carotenoids [130].…”
Section: Novel Products Via Directed Pathway Evolutionmentioning
confidence: 99%